Electrotransfer of Plasmid DNA Encoding an Anti-Mouse Endoglin (CD105) shRNA to B16 Melanoma Tumors with Low and High Metastatic Potential Results in Pronounced Anti-Tumor Effects

被引:14
|
作者
Dolinsek, Tanja [1 ]
Sersa, Gregor [1 ]
Prosen, Lara [1 ]
Bosnjak, Masa [1 ]
Stimac, Monika [1 ]
Razborsek, Urska [1 ]
Cemazar, Maja [1 ,2 ]
机构
[1] Inst Oncol Ljubljana, Dept Expt Oncol, Zaloska 2, SI-1000 Ljubljana, Slovenia
[2] Univ Primorska, Fac Hlth Sci, Polje 42, SI-6310 Izola, Slovenia
来源
CANCERS | 2016年 / 8卷 / 01期
关键词
endoglin; melanoma; gene electrotransfer; electroporation; shRNA; mice; GENE ELECTROTRANSFER; PHASE-I; MALIGNANT-MELANOMA; CANCER; THERAPY; EXPRESSION; ELECTROPORATION; INTERLEUKIN-12; DELIVERY; GROWTH;
D O I
10.3390/cancers8010003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Endoglin overexpression is associated with highly proliferative tumor endothelium and also with some tumors, including melanoma. Its targeting has anti-tumor effectiveness, which can also be obtained by RNA interference. The aim of our study was to explore the anti-tumor effectiveness of endoglin silencing by electrotransfer of plasmid DNA encoding short hairpin RNA against endoglin in two murine B16 melanoma variants with different metastatic potential on cells, spheroids and subcutaneous tumors in mice. The results demonstrate that endoglin silencing with gene electrotransfer reduces the proliferation, survival and migration of melanoma cells and also has anti-tumor effectiveness, as the therapy resulted in a high percentage of tumor cures (23% and 58% on B16F1 and B16F10 tumors, respectively). The effectiveness of the therapy correlated with endoglin expression in melanoma cells; in vitro the effects were more pronounced in B16F1 cells, which express more endoglin than B16F10. However, the opposite was observed in vivo in tumors, where there was a higher expression of endoglin and better anti-tumor effectiveness in the B16F10 tumor. In conclusion, targeting endoglin for the treatment of melanoma seems to be a concept worthy of further exploration due to the increased therapeutic effect of the therapy based on simultaneous vascular targeting and its direct effect on tumor cells.
引用
收藏
页数:14
相关论文
共 4 条
  • [1] In vitro and in vivo effects of an anti-mouse endoglin (CD105)–immunotoxin on the early stages of mouse B16MEL4A5 melanoma tumours
    Raquel Muñoz
    Yolanda Arias
    José Miguel Ferreras
    Pilar Jiménez
    Carmen Langa
    María Angeles Rojo
    Manuel José Gayoso
    Damián Córdoba-Díaz
    Carmelo Bernabéu
    Tomás Girbés
    Cancer Immunology, Immunotherapy, 2013, 62 : 541 - 551
  • [2] In vitro and in vivo effects of an anti-mouse endoglin (CD105)-immunotoxin on the early stages of mouse B16MEL4A5 melanoma tumours
    Munoz, Raquel
    Arias, Yolanda
    Miguel Ferreras, Jose
    Jimenez, Pilar
    Langa, Carmen
    Angeles Rojo, Maria
    Jose Gayoso, Manuel
    Cordoba-Diaz, Damian
    Bernabeu, Carmelo
    Girbes, Tomas
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (03) : 541 - 551
  • [3] Depletion of CD25+T cells and IL-7 administration enhanced anti-tumor effects in mice with B16 melanoma
    Cui, Yongzhi
    Mackall, Crystal
    FASEB JOURNAL, 2008, 22
  • [4] Elimination of CD4+ T cells enhances anti-tumor effect of locally secreted interleukin-12 on B16 mouse melanoma and induces vitiligo-like coat color alteration
    Nagai, H
    Hara, I
    Horikawa, T
    Oka, M
    Kamidono, S
    Ichihashi, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (06) : 1059 - 1064